Q: At the current share price of around Can $3.50 CPG has an enterprise value of about 6 billion ($4 billion in debt and $2 billion in equity). CPG produces about 175,000 boe per day so that means it trade at around Can $34,000 flowing barrel. Isn't that an extremely cheap valuation? If so, could that cheap valuation attract a takeover offer. Even at a 50 per cent premium CPG is trading at a cheap price on a flowing barrel metric. Or is there such a lack of interest in the Canadian oil patch that no body cares that it trades cheaply?
Q: Which of either Sylogist,(syz) or Absolute Software, (abt) do you prefer for growth for a 3/5 year horizon. I recognize that they are in different technological fields, but am leaning slightly toward Absolute.
Q: Hi 5I.
What is your take on these stocks? Debt level and earnings? Next reporting? Growth potential?
Are they worth keeping?
I bought FSZ for income. Is income safe?
Many thanks,
Dick
Q: As much as I enjoy your service, there are times when I find your answers provide insufficient depth. I can understand that when you are asked about obscure companies that most of us have never heard of, but I do expect more, perhaps incorrectly, when the question pertains to companies in your portfolios. Case in point on Feb 6 a question asked what you would recommend , GSY or ECN. Your answer without any support was GSY with no rationale for your choice
On Feb 5, ECN held an information session that provided guidance for 2019.
Management are looking at EPS of 23-25 cents . up from about 11 cents in 2018.
Key sub components are looking quite strong:
Kessler's projections imply earnings growth of close to 40% and revenue growth of around 60%.
Triad is guiding for adjusted operating income to grow around 17%
SFC guidance is for adjusted operating income to grow around 25% in 2019. Originations guidance is expected to be up around 36%. Management believes that the business can grow about 20% annually going forward.
Without getting into them there are other numbers that I have not mentioned that also look quite strong..
The company has been in a transitional phase the last couple of years and there will be some potential losses as ECN sells some of its legacy assets. All in all, it would appear that guidance was extremely positive.
So given this outlook what is it about GSY that makes it a better choice?
Q: I hold a small position in Crius. If the sale to VST goes through at $7.57/share, do I have to take any specific action to get my money, or will the sale proceeds automatically be deposited to my cash account?
Q: How can EIT.Un have a yield of 10.74% given its portfolio? Dividend is $1.20 and the EPS .65, P/E 17.2. Unable to calculate cash flow. You’re comment.
Q: If I hold on to KWN how long do you think it will take until the announced deal is finalized and I get the cash offered by Vistra? Also, what are the likelihoods of the deal collapsing?
Q: Gluskin Sheff if up over 10 per cent today. I can't find any specific news as to why. What's on your radar? Just coming off of an oversold base? Take over rumors?
Q: Your analysis on BCE results, please.
Sold half position in LIF yesterday after a double. Looking to average into BCE in order to de-risk and reduce cyclical volatility in my portfolio.
Q: You don't talk a lot about RUS. It trades at a p/e of 7.2X. very cheap. I know the chart trend is not to good now. Is it worth an investment now or wait a little bit longer? Does 5i recommend or not this stock? Give me your reason why .